South African Medical News

Back to Home Page

Print using browser
Cipla - How to use the Sereflo Synchrobreathe inhaler (fluticasone propionate and salmeterol xinafoate)

ciplalogo




sereflologo.jpg 



sereflounitpack.jpg 


Cipla's brand new breath-actuated inhaler called Sereflo Synchrobreathe. The first and only pMDI breath-actuated inhaler (BAI) with dose counter. 

This document can be printed to give to your customers.



Should your require further information, kindly contact your Cipla Representative or Customer Care on 080 222 6662. 

For information and instructions on how to use Synchrobreathe, please go to www.synchrobreathe.co.za

Cipla thank you for your continued support and assure you of their commitment to service excellence at all times. 

        * This is a drug - read the leaflet carefully before use. 

        * Ask your doctor or pharmacist for further information. 

FOR FULL PRESCRIBING INFORMATION REFER TO THE PACKAGE INSERT APPROVED BY THE MEDICINES REGULATORY AUTHORITY.


MEDPRO PHARMACEUTICA (Ply) Ltd. Reg No 1992/000182/07
CIPLA-MEDPRO (Pty) Ltd. Reg No 1995/004182/07.
CIPLALIFE SCIENCES (Pty) Ltd. Reg No 2000/001167/07
Building 9, Parc du Cap, Mispel Street, Bellville, 7530, RSA. P.O.Box 1096, Durbanville, 7551,RSA.
.


You need to be logged in to see more details. Register Now!


For information and instructions on how to use Synchrobreathe, click here
Contact: Lisl de Villiers, Marketing Manager: Prescription (Respiratory)
Telephone: +27 (0) 21 943 4200
E-mail: Lisl.DeVilliers@cipla.co.za
Date: Friday, September 8, 2017